Voyager Therapeutics, Inc. (VYGR) stock
VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3058% below fair value
$1.52−0.11 (-6.75%)
Close on Nov 17, 2026Market cap $93.66MP/E –Yield –
Voyager Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Voyager Therapeutics's market cap was $107.84M on Nov 11, 2026, against $226.92M a year earlier. Over the last 5 years it ranged from $102.39M to $499.18M, with a median of $256.22M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $107.84M | -50.5% |
| 2025 | Dec 31, 2025 | $218.05M | -29.5% |
| 2024 | Dec 31, 2024 | $309.25M | -16.6% |
| 2023 | Dec 29, 2023 | $370.59M | +57.7% |
| 2022 | Dec 30, 2022 | $234.97M | +129.5% |
| 2021 | Dec 31, 2021 | $102.39M | -61.6% |
| 2020 | Dec 31, 2020 | $266.43M | -48.1% |
| 2019 | Dec 31, 2019 | $513.75M | +69.2% |
| 2018 | Dec 31, 2018 | $303.71M | -30.3% |
| 2017 | Dec 29, 2017 | $435.76M | +34.6% |
| 2016 | Dec 30, 2016 | $323.84M | +979.6% |
| 2015 | Dec 31, 2015 | $30.00M | – |
See a number that looks wrong?